Cortistatin-14 vs Neuropeptide FF — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Cortistatin-14 (CST-14) is an endogenous cyclic neuropeptide structurally related to somatostatin, sharing 11 of 14 amino acids with the somatostatin ring structure. Despite this similarity, cortistatin has distinct receptor binding and biological actions....
Calculate Cortistatin-14 dose →Neuropeptide FF (NPFF) is an endogenous octapeptide first isolated from bovine brain in 1985 and recognized as a key endogenous anti-opioid system component. NPFF is produced in the hypothalamus, brain stem, and spinal cord and acts on NPFF1 and NPFF2 receptors (GPCRs) to oppose ...
Calculate Neuropeptide FF dose →| Parameter | Cortistatin-14 | Neuropeptide FF |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Research | Research |
| Half-Life | Short (minutes) | Short (minutes) |
| Typical Dose | 250-500 mcg (animal) | 0.1-10 nmol (central, animal) |
| Frequency | Variable | Variable |
| Route | Subcutaneous, Intraperitoneal | Intrathecal, Intracerebroventricular (research) |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.